Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Hallucinogen
tryptamine derivative |
| gptkbp:CASNumber |
821-98-1
|
| gptkbp:category |
tryptamines
|
| gptkbp:chemicalFormula |
C18H28N2
|
| gptkbp:firstSynthesized |
gptkb:Alexander_Shulgin
|
| https://www.w3.org/2000/01/rdf-schema#label |
N,N-dibutyltryptamine
|
| gptkbp:IUPACName |
N,N-dibutyl-2-(1H-indol-3-yl)ethanamine
|
| gptkbp:legalStatus |
uncontrolled in many countries
|
| gptkbp:mentions |
gptkb:TIHKAL
|
| gptkbp:molecularWeight |
272.43 g/mol
|
| gptkbp:psychoactive |
short duration
less potent than DMT mild psychedelic |
| gptkbp:PubChem_CID |
12388
|
| gptkbp:relatedTo |
gptkb:DMT
DPT DET |
| gptkbp:routeOfAdministration |
oral
smoked |
| gptkbp:structure |
indole ring with N,N-dibutyl substitution at the ethylamine side chain
|
| gptkbp:bfsParent |
gptkb:5TBO
|
| gptkbp:bfsLayer |
8
|